We create value by making
people’s lives better.
Our actions, business choices and strategies are all based on a single aim: to improve
people’s health worldwide while creating value for our investors. That’s why we tirelessly
drive our business forward: to take care of those who matter most to us.
Since 2017, Bormioli Pharma is a portfolio company of the investment firm Triton. Producing over 5.5 billion items every year and a total turnover of roughly 230 million euros, the company sells its products in more than 100 countries.
Building better businesses
Triton is an international investment firm, founded in 1997. The company’s mission is to contribute to building better long term business projects through partnership. Triton invests in medium-sized businesses whose management is located in Europe and which operate in the Industrial, Business Services and Consumer/Health sectors. Triton’s approximately 100 investors include pension funds, sovereign wealth funds, insurance companies and endowments. Triton focuses on environmental, social and governance criteria in its investment considerations and decision-making processes, because its priority is to create long-term value. Since its founding, Triton has completed more than 60 major investments and supported more than 260 acquisitions.
For more information, please visit: www.triton-partners.com